We see what others don't

About Mundipharma

Opens Page

Our medicines

Opens Page

Careers

Opens Page

Partnering

Opens Page

Latest News

flutiform® receives a positive opinion in Europe for the Treatment of Children with Asthma

Nov 07 2018

Opens Page

FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA

New guidance from ADA and EASD recommends use of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for patients with type 2 diabetes

Oct 16 2018

Opens Page

FOR EU MEDICAL MEDIA ONLY, NOT FOR DISTRIBUTION TO US MEDIA

Mundipharma strengthens position as a leader in biosimilars with acquisition of development company Cinfa Biotech

Oct 10 2018

Opens Page

FOR BUSINESS AND TRADE MEDIA ONLY


The Mundipharma global network of
independent associated companies:

 

Active in more than 
120 worldwide markets;
30 in Europe

 

A presence across
six continents
.

 

Together, these businesses
employ more than
8,600 professionals

 

European sales exceeding
€1 billion and global sales
exceeding $3.4 billion

Supporting patients and communities

As we live longer, providing good quality medical care becomes an increasingly challenging task for the healthcare sector.

Network capabilities

Since our founding by physician entrepreneurs in 1952, the Mundipharma network of independent associated pharmaceutical companies has served the needs of patients and healthcare providers around the globe by providing novel medicines that address unmet medical needs.

Sharing clinical trial information and results

Clinical trial results for studies managed by Mundipharma Research and more information on our disclosure policy are available here.